Cart
sales@molnova.com
Pseudojervine
CAS No. 36069-05-3
Pseudojervine( Jervin-3-glucoside | O-beta-D-Glucopyranosyljervine )
Catalog No. M29248 CAS No. 36069-05-3
Pseudojervine is derived from Veratrum nigrum L. Pseudojervine exhibits feeble inhibition activity against platelet aggregation.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 89 | In Stock |
|
| 5MG | 158 | In Stock |
|
| 10MG | 259 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePseudojervine
-
NoteResearch use only, not for human use.
-
Brief DescriptionPseudojervine is derived from Veratrum nigrum L. Pseudojervine exhibits feeble inhibition activity against platelet aggregation.
-
DescriptionPseudojervine is derived from Veratrum nigrum L. Pseudojervine exhibits feeble inhibition activity against platelet aggregation.
-
In Vitro——
-
In Vivo——
-
SynonymsJervin-3-glucoside | O-beta-D-Glucopyranosyljervine
-
PathwayOthers
-
TargetPlatelet aggregation
-
RecptorPlatelet aggregation
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number36069-05-3
-
Formula Weight587.754
-
Molecular FormulaC33H49NO8
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC[C@@H]1[C@@H]2NC[C@@H](C)C[C@H]2O[C@]11CC[C@H]2[C@@H]3CC=C4C[C@H](CC[C@]4(C)[C@H]3C(=O)C2=C1C)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
48740 RP
48740 RP is an antagonist of platelet-activating factor.
-
SDZ-62-434
SDZ-62-434, a platelet-activating factor inhibitor with antitumor activity, inhibits bombesin- and platelet-derived growth factor-induced DNA synthesis in quiescent Swiss 3T3 cells, making it a potential candidate for studying leukemia, human xenograft colorectal cancer, and lung cancer.
-
NMS-E973
NMS-E973 is a potent and selective Hsp90 inhibitor with DC50 of <10 nM for Hsp90 binding, no activiy against a panel of 52 diverse protein kinases.
